glp 1 agonist new Curious about the latest in weight management and diabetes treatment? Learn about GLP-1/GIP dual agonists. We're enrolling patients for a research study testing this treatment! Want to see if you qualify? Glucagon-like peptide-1 (GLP-1) receptor agonists
Description
In a clinical study of 205 participants, those taking Novo Nordisks pill for 64 weeks lost an average of 16.6% of their body weight among participants who remained on treatment
Roger S
Earlier versions of GLP-1 drugs, such as exenatide (Byetta), increased the risk for pancreatic cancer or certain types of thyroid cancer and even instances of autoimmunity
NMDA, N-methyl-D-aspartate
During hypoglycaemia, insulin secretion is reduced and glucagon secretion is not inhibited
